memantine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Memantine was administered orally to the SCA1 KI mice from 4 weeks of age until death." | 1.42 | Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice. ( Hirai, H; Iizuka, A; Nakamura, K, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iizuka, A | 1 |
| Nakamura, K | 1 |
| Hirai, H | 1 |
| Serra, A | 1 |
| Liao, K | 1 |
| Martinez-Conde, S | 1 |
| Optican, LM | 1 |
| Leigh, RJ | 1 |
2 other studies available for memantine and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in mice.
Topics: Administration, Oral; Animals; Cell Death; Chromosomal Proteins, Non-Histone; Gene Knock-In Techniqu | 2015 |
Suppression of saccadic intrusions in hereditary ataxia by memantine.
Topics: Adult; Aged; Cerebellar Ataxia; Cerebellum; Chromosome Disorders; Chromosomes, Human, Pair 1; Dopami | 2008 |